Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-11

Clinical Trial Update: Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. [NA]

View source ↗

Summary

A clinical trial update comparing Evolut FX and Sapien 3 Ultra Resilia for aortic stenosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolut FX+ (Transcatheter aortic valve)
  • Sapien 3 Ultra Resilia

Snippet

Sponsor: Christian Juhl Terkelsen | Conditions: Aortic Stenosis | NA | Status: RECRUITING